DATE
24/11/2023 - 26/11/2023
TOTAL VIEWS
10428
Google Calendar
ICal
Outlook
Homepage
Videos on Demand
Scientific Program
Contact
e-Certificate
Sponsors
Videos On Demand
24/11/2023
11.30-13.30 | The Most Impactful Antithrombotic Trials in 2022-2023
13.30-14.30 | Clinical Seminar: Uncertainties and challenges in anticoagulation therapy
18.00-19.30 | Meet the Experts session. Hematological disorders and thrombosis
19.30-20.00 | Keynote Lecture
20.00-21.00 | Official Opening of ALPIC 2023
21.00-21.30 | Opening Lecture
25/11/2023
09.30-10.30 | How to Treat Session: Practical Guidance in Antithrombotic Therapy
11.00-12.00 | Advanced Clinical Workshop: Antithrombotics in Coronary Artery Disease
12.00-13.00 | Indications, contraindications, and precautions with the use of DOACs
13.00-13.30 | Lecture
13.30-14.30 | Clinical Seminar. Ischemic stroke prevention in patients with atrial fibrillation
15.30-17.30 | Plenary session: Cancer-Associated Thrombosis. An update
18.00-19.30 | Factor XI (FXI) Inhibitors: The future of anticoagulants
19.30-20.00 | Keynote Lecture
20.00-21.30 | Meet the Experts: Recent guidelines on antithrombotic management
26/11/2023
09.00-10.30 | How to treat session: DOACS in pediatric medicine
11.00-11.30 | Lecture
11.30-12.30 | Challenging the thrombosis risk and management in Women
12.30-14.00 | Meet the Experts: Pathogenesis, Prevention and Management of Ischemic Stroke
24/11/2023
11.30-13.30 | The Most Impactful Antithrombotic Trials in 2022-2023
ATLANTIS-4D-CT | Stylianos Daios
170 Views
RE-SPECT CVT | Dimitrios Sagris
138 Views
PEITHO-3 | Eleftheria Ztriva
148 Views
BEMICOP | Vasiliki Dourliou
134 Views
RIVA-SVT 100 | Adonis Protopapas
173 Views
The role of ADAMTS13 in ischemic strokes | Michalis Makris
121 Views
Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial | Elias S. Kyriakou
131 Views
13.30-14.30 | Clinical Seminar: Uncertainties and challenges in anticoagulation therapy
A patient with renal insufficiency - What is the optimal anticoagulation? | Nikolaos Kakaletsis
179 Views
Subclinical atrial fibrillation is detected in a patient - When to anticoagulate? | Dimitrios N. Nikas
124 Views
Anticoagulant Reversal Agents: Who, What, When, and How? | Emmanouil Papadakis
132 Views
Antithrombotic therapy in patients undergoing Cardiac Surgery | Dimitrios Iliopoulos
123 Views
18.00-19.30 | Meet the Experts session. Hematological disorders and thrombosis
Thromboinflammation and sickle cell disease | Efthymia Vlachaki
120 Views
Multiple myeloma - associated coagulopathy | Eirini Katοdritou
139 Views
Thrombotic complications of myeloproliferative neoplasms | George Vassilopoulos
123 Views
Mechanisms and management of coagulopathy in acute promyelocytic leukemia | Vasileios Perifanis
120 Views
Relationship between ABO blood group type and risk of thrombosis | Fotios Girtovitis
136 Views
PNH and risk of thrombosis | Eleni Gavriilaki
134 Views
19.30-20.00 | Keynote Lecture
Atrial fibrillation and cancer: Prevalence and relative risk from a nationwide study | Konstantinos Pappas
126 Views
20.00-21.00 | Official Opening of ALPIC 2023
Official Opening of ALPIC 2023
132 Views
21.00-21.30 | Opening Lecture
Immunothrombosis in acute and chronic tissue damage | Panagiotis Skendros
125 Views
25/11/2023
09.30-10.30 | How to Treat Session: Practical Guidance in Antithrombotic Therapy
Laboratory monitoring of platelet functionality | Dimitrios A. Tsakiris
127 Views
Should all stroke patients undergo thrombophilia testing | Georgia Kaiafa
126 Views
Pros and cons of elevated D-dimmers | Konstantina Papathanasiou
134 Views
11.00-12.00 | Advanced Clinical Workshop: Antithrombotics in Coronary Artery Disease
Antithrombotic Treatment before, during and after PCI | Pavlos Roditis
114 Views
Bleeding after an ACS: what are you doing with the antithrombotic therapy | Konstantinos Tsioufis
119 Views
12.00-13.00 | Indications, contraindications, and precautions with the use of DOACs
DOACs for AF in elderly patients | Christos Lafaras
135 Views
Anticoagulation and Stroke Prevention for AF: Stroke Prophylaxis in Complicated Cases | Eleni Korompoki
134 Views
End-Stage Renal Disease and Haemodialysis. Antiplatelets - Anticoagulants | Pantelis Sarafidis
132 Views
13.00-13.30 | Lecture
Individualized antithrombotic therapies in Diabetics | Triantafyllos Didangelos
123 Views
13.30-14.30 | Clinical Seminar. Ischemic stroke prevention in patients with atrial fibrillation
The role of cardiac magnetic resonance in patients with atrial fibrillation | Theodoros Karamitsos
116 Views
The burden of atrial fibrillation: effectiveness and safety of DOACs | Georgios Ntaios
118 Views
Dissolving the thrombus in a patient on anticoagulation | Panagiotis Papanagiotou
116 Views
15.30-17.30 | Plenary session: Cancer-Associated Thrombosis. An update
New insights into the mechanisms underlying CAT pathogenesis | Alexandros Tselepis
116 Views
Assessment of bleeding risk in cancer patients | Stavroula Tsiara
124 Views
LMWH or DOACs for management of cancer-associated VTE | James D. Douketis
134 Views
Tailoring anticoagulation beyond six months | Nikolaos G. Tsoukalas
120 Views
Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal Cancer | Marina Marchetti
144 Views
18.00-19.30 | Factor XI (FXI) Inhibitors: The future of anticoagulants
FXI inhibitors as Novel Agents to Maximize Safety and Maintain Efficacy in Thromboembolic Disease | Alexandros Tselepis
128 Views
Recent data from the clinical assessment of the anti-FXI inhibitors in Atrial Fibrillation | Katerina Naka
144 Views
Recent data from the clinical assessment of the anti-FXI inhibitors in Non cardioembolic ischemic stroke | Μatilda Florentin
117 Views
19.30-20.00 | Keynote Lecture
Deep vein thrombosis and pulmonary embolism in cancer patients | Anna Falanga
122 Views
20.00-21.30 | Meet the Experts: Recent guidelines on antithrombotic management
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer | Ismail Elalamy
125 Views
Acute, periprocedural and long-term antithrombotic therapy in older adults. 2022 Update by the ESC Working Group on Thrombosis | Joao Morais
135 Views
European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases | Stavros Kakkos
121 Views
26/11/2023
09.00-10.30 | How to treat session: DOACS in pediatric medicine
Treatment of pediatric VTE- is the standard of care changing? | Emmanouel Hatzipantelis
119 Views
Treatment and outcome of cerebral sinovenous thrombosis (CSVT) in children | Thomas J. Tegos
132 Views
Central venous Line (CVL)-associated thrombosis in paediatric practice | Zacharoula Karabouta
121 Views
Hypertension as a risk factor for stroke in children | Stella Stabouli
119 Views
11.00-11.30 | Lecture
Perioperative management of DOACs | Petros Tzimas
122 Views
11.30-12.30 | Challenging the thrombosis risk and management in Women
Hormones, venous and arterial thrombosis in Women | Ploutarchos Tzoulis
125 Views
To screen or not to screen for thrombophilia in a Pregnant Women or in a Women trying to conceive? | Eleftheria Lefkou
163 Views
12.30-14.00 | Meet the Experts: Pathogenesis, Prevention and Management of Ischemic Stroke
Optimal blood pressure levels in Acute Phase of stroke | Nikolaos Kakaletsis
126 Views
Clinical relevance of adverse remodeling of microcirculation in Hypertensives and the level of cerebral circulation | Christos Savopoulos
115 Views
ABPM Versus office BP measurements and newer cuffless techniques | Vasileios Kotsis
103 Views
Hypertension post stroke: how to treat | Kalliroi Kalantzi
124 Views
Scientific Program
×
